FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079681602> ?p ?o ?g. }

• W2079681602 endingPage "638" @default.
• W2079681602 startingPage "634" @default.
• W2079681602 abstract "We investigated the activity and toxicity of a combination of vinorelbine (VNB), paclitaxel (PTX) and 5-fluorouracil (5-FU) continuous infusion administered as first-line chemotherapy in metastatic breast cancer patients pretreated with adjuvant anthracyclines. A total of 61 patients received a regimen consisting of VNB 25 mg m(-2) on days 1 and 15, PTX 60 mg m(-2) on days 1, 8 and 15 and continuous infusion of 5-FU at 200 mg m(-2) every day. Cycles were repeated every 28 days. Disease response was evaluated by both RECIST and World Health Organization (WHO) criteria. Objective responses were recorded in 39 of 61 patients (64.0%) assessed by WHO and in 36 of 50 patients (72.0%) assessable by RECIST criteria. Complete remission occurred in 15 (24.6%) and 14 patients (28.0%), respectively. The median time to progression and overall survival of entire population was 10.6 and 27.3 months, respectively, and median duration of complete response was 14.8 months. The dose-limiting toxicity was myelosuppression (leucopenia grade 3/4 in 52.5% of patients). Grade 3/4 nonhaematologic toxicities included mucositis/diarrhoea in 13.1%, skin in 3.3% and cardiac in 1.6% of patients. Grade 2/3 neurotoxicity was observed in five patients (7.2%). The VNB, PTX and 5-FU continuous infusion combination regimen was active and manageable. Complete responses were frequent and durable." @default.
• W2079681602 created "2016-06-24" @default.
• W2079681602 creator A5007488646 @default.
• W2079681602 creator A5010499606 @default.
• W2079681602 creator A5013171716 @default.
• W2079681602 creator A5019107001 @default.
• W2079681602 creator A5020078965 @default.
• W2079681602 creator A5020736353 @default.
• W2079681602 creator A5022648629 @default.
• W2079681602 creator A5027971272 @default.
• W2079681602 creator A5029010702 @default.
• W2079681602 creator A5029949952 @default.
• W2079681602 creator A5050426287 @default.
• W2079681602 creator A5065176823 @default.
• W2079681602 creator A5073879276 @default.
• W2079681602 creator A5077674568 @default.
• W2079681602 creator A5082385634 @default.
• W2079681602 creator A5090055323 @default.
• W2079681602 creator A5090257152 @default.
• W2079681602 date "2005-01-25" @default.
• W2079681602 modified "2023-10-06" @default.
• W2079681602 title "Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines" @default.
• W2079681602 cites W1755746957 @default.
• W2079681602 cites W1823056587 @default.
• W2079681602 cites W1946819517 @default.
• W2079681602 cites W1949548665 @default.
• W2079681602 cites W1964072107 @default.
• W2079681602 cites W1976666735 @default.
• W2079681602 cites W1978072892 @default.
• W2079681602 cites W2000160960 @default.
• W2079681602 cites W2018383869 @default.
• W2079681602 cites W2021221301 @default.
• W2079681602 cites W2022550413 @default.
• W2079681602 cites W2023779015 @default.
• W2079681602 cites W2023999405 @default.
• W2079681602 cites W2027740621 @default.
• W2079681602 cites W2029409133 @default.
• W2079681602 cites W2048553013 @default.
• W2079681602 cites W2050978291 @default.
• W2079681602 cites W2054351138 @default.
• W2079681602 cites W2055881350 @default.
• W2079681602 cites W2065403309 @default.
• W2079681602 cites W2100230735 @default.
• W2079681602 cites W2117206082 @default.
• W2079681602 cites W2139248078 @default.
• W2079681602 cites W2167805334 @default.
• W2079681602 cites W2325349238 @default.
• W2079681602 cites W2405368760 @default.
• W2079681602 cites W2414696008 @default.
• W2079681602 cites W2416997884 @default.
• W2079681602 doi "https://doi.org/10.1038/sj.bjc.6602335" @default.
• W2079681602 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2361889" @default.
• W2079681602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15668714" @default.
• W2079681602 hasPublicationYear "2005" @default.
• W2079681602 type Work @default.
• W2079681602 sameAs 2079681602 @default.
• W2079681602 citedByCount "10" @default.
• W2079681602 countsByYear W20796816022020 @default.
• W2079681602 countsByYear W20796816022021 @default.
• W2079681602 countsByYear W20796816022022 @default.
• W2079681602 countsByYear W20796816022023 @default.
• W2079681602 crossrefType "journal-article" @default.
• W2079681602 hasAuthorship W2079681602A5007488646 @default.
• W2079681602 hasAuthorship W2079681602A5010499606 @default.
• W2079681602 hasAuthorship W2079681602A5013171716 @default.
• W2079681602 hasAuthorship W2079681602A5019107001 @default.
• W2079681602 hasAuthorship W2079681602A5020078965 @default.
• W2079681602 hasAuthorship W2079681602A5020736353 @default.
• W2079681602 hasAuthorship W2079681602A5022648629 @default.
• W2079681602 hasAuthorship W2079681602A5027971272 @default.
• W2079681602 hasAuthorship W2079681602A5029010702 @default.
• W2079681602 hasAuthorship W2079681602A5029949952 @default.
• W2079681602 hasAuthorship W2079681602A5050426287 @default.
• W2079681602 hasAuthorship W2079681602A5065176823 @default.
• W2079681602 hasAuthorship W2079681602A5073879276 @default.
• W2079681602 hasAuthorship W2079681602A5077674568 @default.
• W2079681602 hasAuthorship W2079681602A5082385634 @default.
• W2079681602 hasAuthorship W2079681602A5090055323 @default.
• W2079681602 hasAuthorship W2079681602A5090257152 @default.
• W2079681602 hasBestOaLocation W20796816021 @default.
• W2079681602 hasConcept C121608353 @default.
• W2079681602 hasConcept C126322002 @default.
• W2079681602 hasConcept C141071460 @default.
• W2079681602 hasConcept C2776694085 @default.
• W2079681602 hasConcept C2778239845 @default.
• W2079681602 hasConcept C2778397455 @default.
• W2079681602 hasConcept C2778496288 @default.
• W2079681602 hasConcept C2780350996 @default.
• W2079681602 hasConcept C2780456651 @default.
• W2079681602 hasConcept C2781413609 @default.
• W2079681602 hasConcept C2908647359 @default.
• W2079681602 hasConcept C29730261 @default.
• W2079681602 hasConcept C530470458 @default.
• W2079681602 hasConcept C71924100 @default.
• W2079681602 hasConcept C90924648 @default.
• W2079681602 hasConcept C99454951 @default.
• W2079681602 hasConceptScore W2079681602C121608353 @default.
• W2079681602 hasConceptScore W2079681602C126322002 @default.

• next